QUEST DIAGNOSTICS INCORPORATED for QUEST DIAGNOSTICS INCORPORATED
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Monitor implementation of H.R. 1865, Further Consolidated Appropriations Act, 2020, (Public Law No: 116-94) and provisions related to policies regarding data collection from laboratories under the Protecting Access to Medicare Act (PAMA). H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law No: 116-136), and provisions related to clinical laboratory testing for COVID-19 and laboratory data collection and reimbursement under PAMA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHERRY HARPER WIDICUS New | — |
Health Issues HCR
Laboratory Developed Test (LDT) reform pathway engagement. H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19. FY2021 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations as it relates to regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing. FY2021 CDC appropriations for improved pediatric reference intervals and harmonizing the reporting of clinical laboratory test results.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHERRY HARPER WIDICUS New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.